Experts Dissect What Confusing New Vax Rules Could Mean for Kids, Parents

The committee that sets national vaccine recommendations voted to change policies surrounding two major childhood inoculations after gathering last week for two days of contentious and chaotic meetings.

The 12 members, who were recently handpicked by controversial Health and Human Services Secretary Robert F. Kennedy Jr., also debated overturning decades of established practice around hepatitis B shots for newborns, though they ultimately tabled that vote.

The other two shots in play were the measles, mumps, rubella and varicella (chickenpox) combination vaccine, also known as MMRV, and this year’s COVID 19 booster.

By the end of the week, the Advisory Committee on Immunization Practices, also known as ACIP, voted to no longer recommend the MMRV combination vaccine for kids under 4 years old, rendering it largely inaccessible for that age group.

The committee also voted to shift the COVID 19 booster recommendation to “shared clinical decision making” for all people over 6 months old — regardless of age or risk level — meaning that before getting the shot, individuals will need to talk through the pros and cons with a health care provider, which includes pharmacists.

Through this departure, the committee largely preserved access and insurance coverage, while also raising doubts about the effectiveness and safety of the vaccine, at times citing debunked theories.

“There is just widespread confusion about, ‘What should I do as a parent? Who should I listen to?’” said Northe Saunders, executive director of the pro-vaccine advocacy organization American Families for Vaccines, formerly called SAFE Communities Coalition.

“American parents and American providers don’t actually know what the best recommendations are anymore,” he added, “and so that is going to lead to more hesitancy, because there’s uncertainty about what the right thing to do is, and that’s going to lead to declining immunization rates.”